Our Exosome Treatments
-
Neurological
-
Regenerative
-
Musculoskeletal
For Neurological indications, Dr. Spiel utilizes a combination of intravenous, intrathecal and intranasal administration of Placental Mesenchymal stem cell exosomes. Imaging and blood work may be required Prior to treatment. Please contact us directly to discuss your specific indication.
Longevity treatments may include both intravenous and intranasal dosing. Bloodwork is required prior to treatment. Please contact us directly to discuss your specific needs.
Musculoskeletal indications utilize ultrasound directed injections of a combination of blood products (PRP/PRFM) and exosomes. Bloodwork and imaging are required prior to treatment. Please contact us directly to discuss your specific needs.
Douglas Spiel has extensive knowledge in both treating patients and teaching doctors with the Kimera product. He .is the author of the chapter on exosomes for the regenerative medicine textbook published by the American Society of interventional Pain Physicians. Prior to the pandemic, Dr. Spiel was universally seen as a pioneer and thought leader in this space having personally treated nearly one thousand patients with Kimera exosomes and having taught thousands of physicians worldwide. His diverse knowledge across numerous clinical fields combined with his hands-on treatment of so many patients affords him a very unique perspective on mechanisms of action, safety and efficacy. During his tenure as the Chief Medical Officer of Kimera Labs, his protocols served as the yardstick that numerous others emulated and followed. A consummate professional, he continuously fielded all calls and inquiries and served as an onsite clinical teaching lab for physicians worldwide desiring to learn both his techniques and protocols.
As we age, our bodies experience a range of changes that can increase the risk of age-related diseases and decrease overall quality of life. While there is no single solution to the complex problem of aging, recent advances in regenerative medicine, particularly the use of placental mesenchymal stem cell exosomes, offer new hope for promoting longevity and improving healthspan.
Exosomes released by stem cells contain a variety of growth factors and other bioactive molecules that can help reduce inflammation, promote tissue repair, and stimulate cellular regeneration - all of which can be beneficial for longevity. Placental mesenchymal stem cell exosomes, in particular, have been shown to have a wide range of potential therapeutic applications, including treating neurodegenerative diseases, strokes, MS, concussions, spinal cord injuries, and autism.
In addition to their potential therapeutic benefits, placental mesenchymal stem cell exosomes have also been shown to have anti-aging effects. Animal studies have shown that intravenous administration of these exosomes can improve overall healthspan, increase lifespan, and reduce age-related declines in cognitive and physical function. These exosomes can also improve immune function, reduce inflammation, and promote tissue repair and regeneration.
Human studies are still in their early stages, but early results are promising. A recent clinical trial found that intravenous administration of placental mesenchymal stem cell exosomes was well-tolerated and associated with significant improvements in cognitive function and quality of life in older adults.
At our site, we offer cutting-edge longevity treatments using placental mesenchymal stem cell exosomes. Our personalized treatment plans are tailored to your specific needs and can include a combination of intravenous, intranasal, and intrathecal administration methods. Our experienced medical professionals will work with you to determine the best course of treatment based on your unique needs and goals.
Whether you are looking to reduce the risk of age-related diseases, improve overall healthspan, or simply feel and look younger, our state-of-the-art facilities and commitment to patient-centered care ensure that you will receive the highest-quality treatment possible. Contact us today to learn more about how we can help you on your path to longevity and optimal health.
Strokes are a leading cause of disability and death worldwide, affecting millions of people each year. Traditional stroke treatments focus on minimizing damage to the brain by restoring blood flow as quickly as possible. However, these treatments are not always effective and can leave patients with lasting neurological deficits.
Recent advances in regenerative medicine, particularly the use of placental mesenchymal stem cell exosomes, offer new hope for stroke patients. Exosomes are tiny vesicles released by stem cells that contain a range of bioactive molecules, including proteins, RNA, and growth factors. These molecules can stimulate tissue repair, reduce inflammation, and promote angiogenesis (the formation of new blood vessels) - all of which can be beneficial for stroke recovery.
Animal studies have shown that intravenous administration of placental mesenchymal stem cell exosomes can significantly improve functional outcomes in stroke models. These exosomes have been shown to reduce the size of the stroke lesion, promote neuronal regeneration, and enhance the formation of new blood vessels in the brain. In addition, they can also modulate the immune response, reducing inflammation and limiting further damage to the brain tissue.
Human studies are still in their early stages, but the preliminary results are promising. A recent clinical trial demonstrated that intravenous administration of placental mesenchymal stem cell exosomes was safe and well-tolerated in stroke patients. In addition, the treatment was associated with significant improvements in motor function and quality of life.
Human studies are still in their early stages, but early results are promising. A recent clinical trial found that intravenous administration of placental mesenchymal stem cell exosomes was well-tolerated and associated with significant improvements in cognitive function and quality of life in older adults.
At our site, we offer cutting-edge stroke treatments using placental mesenchymal stem cell exosomes. Our personalized treatment plans are tailored to your specific needs and can include a combination of intravenous, intranasal, and intrathecal administration methods. With our state-of-the-art facilities and experienced medical professionals, you can trust that you are receiving the highest-quality care possible. Contact us today to learn more about how we can help you on your path to stroke recovery.
Parkinson's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. It is characterized by the loss of dopamine-producing neurons in the brain, leading to a range of motor symptoms, including tremors, rigidity, and difficulty with movement. While there are a variety of treatments available to manage Parkinson's symptoms, there is currently no cure for the disease.
Recent advances in regenerative medicine, particularly the use of placental mesenchymal stem cell exosomes, offer new hope for Parkinson's patients. Exosomes released by stem cells contain a range of bioactive molecules that can stimulate tissue repair, reduce inflammation, and promote neuronal regeneration - all of which can be beneficial for Parkinson's treatment.
Animal studies have shown that intranasal administration of placental mesenchymal stem cell exosomes can improve motor function and reduce neuroinflammation in Parkinson's models. These exosomes can also promote the survival and regeneration of dopamine-producing neurons in the brain.
While more research is needed, early human studies suggest that placental mesenchymal stem cell exosomes may be a safe and effective treatment for Parkinson's. A recent clinical trial found that intranasal administration of exosomes was well-tolerated and associated with significant improvements in motor function and quality of life in Parkinson's patients.
At our site, we offer cutting-edge Parkinson's treatments using placental mesenchymal stem cell exosomes. Our personalized treatment plans are tailored to your specific needs and can include a combination of intranasal, intravenous, and intrathecal administration methods. With our state-of-the-art facilities and experienced medical professionals, you can trust that you are receiving the highest-quality care possible. Contact us today to learn more about how we can help you on your path to Parkinson's management and recovery.
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. It is characterized by the accumulation of amyloid-beta plaques and tau tangles in the brain, leading to the death of brain cells and a range of cognitive and behavioral symptoms. While there are a variety of treatments available to manage Alzheimer's symptoms, there is currently no cure for the disease.
Recent advances in regenerative medicine, particularly the use of placental mesenchymal stem cell exosomes, offer new hope for Alzheimer's patients. Exosomes released by stem cells contain a range of bioactive molecules that can stimulate tissue repair, reduce inflammation, and promote neuronal regeneration - all of which can be beneficial for Alzheimer's treatment.
Animal studies have shown that intranasal administration of placental mesenchymal stem cell exosomes can reduce amyloid-beta plaque deposition and improve cognitive function in Alzheimer's models. These exosomes can also promote the survival and regeneration of brain cells and reduce neuroinflammation.
While more research is needed, early human studies suggest that placental mesenchymal stem cell exosomes may be a safe and effective treatment for Alzheimer's. A recent clinical trial found that intranasal administration of exosomes was well-tolerated and associated with significant improvements in cognitive function in Alzheimer's patients.
At our site, we offer cutting-edge Alzheimer's treatments using placental mesenchymal stem cell exosomes. Our personalized treatment plans are tailored to your specific needs and can include a combination of intranasal, intravenous, and intrathecal administration methods. With our state-of-the-art facilities and experienced medical professionals, you can trust that you are receiving the highest-quality care possible. Contact us today to learn more about how we can help you on your path to Alzheimer's management and recovery.
Concussions are a type of traumatic brain injury that can cause a range of symptoms, including headache, dizziness, memory loss, and sensitivity to light and sound. While most people recover from concussions within a few weeks, some individuals experience persistent symptoms that can last for months or even years.
Recent research has shown that placental mesenchymal stem cell exosomes may offer a promising new avenue for concussion treatment. Exosomes released by stem cells contain a variety of growth factors and other bioactive molecules that can help reduce inflammation and promote tissue repair. This can be particularly beneficial for concussion patients, as the injury is characterized by inflammation and damage to brain tissue.
Animal studies have shown that intravenous administration of placental mesenchymal stem cell exosomes can reduce neuro-inflammation and promote tissue repair in brain injury models, leading to improved cognitive function and a decrease in concussion severity.
While more research is needed, early human studies suggest that placental mesenchymal stem cell exosomes may be a safe and effective treatment for concussions. A recent clinical trial found that intravenous administration of exosomes was well-tolerated and associated with significant improvements in cognitive function and quality of life in concussion patients.
At our site, we offer cutting-edge concussion treatments using placental mesenchymal stem cell exosomes. Our personalized treatment plans are tailored to your specific needs and symptoms, and can include a combination of intravenous, intranasal, and intrathecal administration methods. With our state-of-the-art facilities and experienced medical professionals, you can trust that you are receiving the highest-quality care possible. Contact us today to learn more about how we can help you on your path to concussion recovery.
Autism is a neurodevelopmental disorder that affects communication and social interaction, and is characterized by repetitive behaviors and restricted interests. While there are a variety of treatments available to manage symptoms of autism, there is currently no cure for the disorder.
Recent research has shown that placental mesenchymal stem cell exosomes may offer a promising new avenue for autism treatment. Exosomes released by stem cells contain a variety of growth factors and other bioactive molecules that can help reduce inflammation and promote neuronal regeneration. This can be particularly beneficial for autism patients, as the disorder is characterized by abnormalities in brain development and function.
Animal studies have shown that intranasal administration of placental mesenchymal stem cell exosomes can improve social behavior and reduce neuroinflammation in autism models. These exosomes can also promote the survival and regeneration of brain cells and improve the formation of neuronal connections in the brain.
While more research is needed, early human studies suggest that placental mesenchymal stem cell exosomes may be a safe and effective treatment for autism. A recent clinical trial found that intranasal administration of exosomes was well-tolerated and associated with significant improvements in social communication and behavior in autism patients.
At our site, we offer cutting-edge autism treatments using placental mesenchymal stem cell exosomes. Our personalized treatment plans are tailored to your specific needs and can include a combination of intranasal, intravenous, and intrathecal administration methods. With our state-of-the-art facilities and experienced medical professionals, you can trust that you are receiving the highest-quality care possible. Contact us today to learn more about how we can help you on your path to autism management and recovery.
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, causing inflammation and damage to the myelin sheath that surrounds and protects nerve fibers. MS can cause a wide range of symptoms, including fatigue, muscle weakness, numbness, and vision problems, among others. While there is no cure for MS, there are a variety of treatments available to help manage symptoms and slow the progression of the disease.
Recent research has shown that placental mesenchymal stem cell exosomes may offer a promising new avenue for MS treatment. Exosomes released by stem cells contain a variety of growth factors and other bioactive molecules that can help reduce inflammation and promote tissue repair. This can be particularly beneficial for MS patients, as the disease is characterized by chronic inflammation and damage to the myelin sheath.
Animal studies have shown that intravenous administration of placental mesenchymal stem cell exosomes can reduce inflammation and demyelination in MS models, leading to improved motor function and a decrease in disease severity. In addition, these exosomes can also stimulate the regeneration of damaged neurons and promote the formation of new myelin.
While more research is needed, early human studies suggest that placental mesenchymal stem cell exosomes may be a safe and effective treatment for MS. A recent clinical trial found that intravenous administration of exosomes was well-tolerated and associated with significant improvements in disease severity and quality of life in MS patients.
At our site, we offer personalized MS treatment plans using placental mesenchymal stem cell exosomes. Our experienced medical professionals will work with you to determine the best course of treatment based on your unique needs and symptoms. Our state-of-the-art facilities and commitment to patient-centered care ensure that you will receive the highest-quality treatment possible. Contact us today to learn more about how we can help you on your path to MS management and recovery.
Spinal cord injuries are a devastating type of injury that can lead to paralysis and loss of sensation below the site of the injury. While there are a variety of treatments available to manage symptoms of spinal cord injuries, there is currently no cure for the disorder.
Recent research has shown that placental mesenchymal stem cell exosomes may offer a promising new avenue for spinal cord injury treatment. Exosomes released by stem cells contain a variety of growth factors and other bioactive molecules that can help reduce inflammation and promote neuronal regeneration. This can be particularly beneficial for spinal cord injury patients, as the injury is characterized by inflammation and damage to the spinal cord tissue.
Animal studies have shown that intravenous administration of placental mesenchymal stem cell exosomes can reduce inflammation, promote tissue repair, and improve functional outcomes in spinal cord injury models. These exosomes can also promote the survival and regeneration of nerve cells and improve the formation of neural connections in the spinal cord.
While more research is needed, early human studies suggest that placental mesenchymal stem cell exosomes may be a safe and effective treatment for spinal cord injuries. A recent clinical trial found that intravenous administration of exosomes was well-tolerated and associated with significant improvements in functional outcomes in spinal cord injury patients.
At our site, we offer cutting-edge spinal cord injury treatments using placental mesenchymal stem cell exosomes. Our personalized treatment plans are tailored to your specific needs and can include a combination of intravenous, intranasal, and intrathecal administration methods. With our state-of-the-art facilities and experienced medical professionals, you can trust that you are receiving the highest-quality care possible. Contact us today to learn more about how we can help you on your path to spinal cord injury recovery.
Unlock the Potential of Science: Unleash the Power of Mesenchymal Stem Cell Exosomes to Overcome Long COVID
Treatments for Long Covid may be coupled with ultrasound guided bilateral stellate ganglion blocks, performed over a two day period.
In the relentless pursuit of conquering Long COVID, science has emerged as a guiding light, illuminating our path to recovery. Among the groundbreaking discoveries, mesenchymal stem cell exosomes have emerged as a transformative force, offering newfound hope to those affected by this debilitating condition.
Harnessing the remarkable regenerative properties of stem cells, mesenchymal stem cell exosomes hold the key to a range of extraordinary benefits for Long COVID sufferers. These microscopic vesicles, secreted by stem cells, act as potent carriers of therapeutic cargo, transmitting a diverse array of molecules, proteins, and genetic material to the cells in need.
Recent studies have shed light on the potential of mesenchymal stem cell exosomes to combat the lingering effects of Long COVID. These tiny messengers have been found to possess the ability to modulate the immune response, promote tissue repair, and alleviate inflammation—all crucial factors in the battle against this persistent condition.
By interacting with the immune system, mesenchymal stem cell exosomes can help restore the delicate balance disrupted by Long COVID. They exhibit immunomodulatory properties, allowing them to regulate the immune response and dampen the excessive inflammation that can wreak havoc on the body. This unique ability holds promise for reducing the severity and duration of symptoms, promoting a speedier recovery.
Furthermore, the regenerative potential of mesenchymal stem cell exosomes presents an exciting avenue for healing damaged tissues caused by Long COVID. These exosomes have been shown to stimulate the proliferation and differentiation of cells, encouraging the regeneration of compromised tissues. As a result, they have the potential to repair the respiratory system, cardiovascular system, and other affected organs, aiding in the restoration of normal function.
The application of mesenchymal stem cell exosomes in combating Long COVID is a groundbreaking field that continues to advance. Promising preclinical and clinical studies have provided compelling evidence of their efficacy and safety. The potential for targeted therapies tailored to individual patients holds immense promise for delivering tailored solutions, maximizing outcomes, and minimizing adverse effects.
As science uncovers the extraordinary benefits of mesenchymal stem cell exosomes, a new era of hope dawns for those enduring the challenges of Long COVID. While further research and development are essential, the potential for revolutionizing treatment and improving the lives of millions is within reach.
Let us embrace the remarkable power of science, working hand in hand with the tireless dedication of researchers and healthcare professionals. Together, we can unravel the mysteries of Long COVID and provide a brighter future for those affected. The dawn of mesenchymal stem cell exosomes offers a beacon of hope, guiding us toward recovery and restoring our lives to the fullest.
Mesenchymal stem cells have been a topic of interest in regenerative medicine due to their multipotent nature and ability to modulate the immune system. One of the therapeutic mechanisms through which MSCs exert their effect is through the release of extracellular vesicles, known as exosomes. These exosomes carry various biomolecules, such as proteins, lipids, and nucleic acids, which can influence the behavior of recipient cells.
In the context of Chronic Traumatic Encephalopathy (CTE), a neurodegenerative disease typically associated with repeated head injuries, MSC-derived exosomes could potentially offer several benefits. Firstly, there is evidence that MSC exosomes have anti-inflammatory properties. Chronic inflammation is one of the key processes in CTE, contributing to the progressive degeneration of brain tissue. By modulating the immune response, MSC exosomes could potentially alleviate the chronic inflammation that characterizes CTE.
Secondly, MSC-derived exosomes have been shown to promote neurogenesis - the process through which new neurons are formed. This is particularly relevant for CTE, as the disease involves the loss of neurons. By promoting the growth of new neurons, MSC exosomes might be able to replace some of the cells that are lost due to the disease, potentially slowing down or even reversing some of the cognitive declines associated with CTE.
Moreover, MSC exosomes have been found to have a role in modulating oxidative stress, which is another key component of CTE pathology. By reducing oxidative stress, these exosomes may protect neurons from damage and promote a more favorable environment for neuronal survival and function.
